Literature DB >> 15644449

Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion.

John Schmieg1, Guangli Yang, Richard W Franck, Nico Van Rooijen, Moriya Tsuji.   

Abstract

It has been shown that dendritic cells (DCs) are able to present glycolipids to natural killer (NK) T cells in vivo. However, the essential role of DCs, as well as the role of other cells in glycolipid presentation, is unknown. Here, we show that DCs are the crucial antigen-presenting cells (APCs) for splenic NK T cells, whereas Kupffer cells are the key APCs for hepatic NK T cells. Both cell types stimulate cytokine production by NK T cells within 2 h of glycolipid administration, but only DCs are involved in the systemic, downstream responses to glycolipid administration. More specifically, CD8alpha+ DCs produce IL-12 in response to glycolipid presentation, which stimulates secondary IFN-gamma production by NK cells in different organs. Different APCs participate in glycolipid presentation to NK T cells in vivo but differ in their involvement in the overall glycolipid response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15644449      PMCID: PMC545847          DOI: 10.1073/pnas.0408288102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells.

Authors:  G Eberl; H R MacDonald
Journal:  Eur J Immunol       Date:  2000-04       Impact factor: 5.532

Review 2.  NKT cells: facts, functions and fallacies.

Authors:  D I Godfrey; K J Hammond; L D Poulton; M J Smyth; A G Baxter
Journal:  Immunol Today       Date:  2000-11

3.  Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation.

Authors:  G Eberl; P Brawand; H R MacDonald
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

4.  Requirement for IFN-gamma in IL-12 production induced by collaboration between v(alpha)14(+) NKT cells and antigen-presenting cells.

Authors:  Y F Yang; M Tomura; S Ono; T Hamaoka; H Fujiwara
Journal:  Int Immunol       Date:  2000-12       Impact factor: 4.823

Review 5.  Biology and molecular epidemiology of diphtheria toxin and the tox gene.

Authors:  R K Holmes
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

6.  The C-glycoside analogue of the immunostimulant alpha-galactosylceramide (KRN7000): synthesis and striking enhancement of activity.

Authors:  Guangli Yang; John Schmieg; Moriya Tsuji; Richard W Franck
Journal:  Angew Chem Int Ed Engl       Date:  2004-07-19       Impact factor: 15.336

7.  Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells.

Authors:  Z Trobonjaca; F Leithäuser; P Möller; R Schirmbeck; J Reimann
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

8.  Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets.

Authors:  H Hochrein; K Shortman; D Vremec; B Scott; P Hertzog; M O'Keeffe
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

9.  Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo.

Authors:  Marc Dalod; Thais P Salazar-Mather; Lene Malmgaard; Casey Lewis; Carine Asselin-Paturel; Francine Brière; Giorgio Trinchieri; Christine A Biron
Journal:  J Exp Med       Date:  2002-02-18       Impact factor: 14.307

10.  Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.

Authors:  J L Matsuda; O V Naidenko; L Gapin; T Nakayama; M Taniguchi; C R Wang; Y Koezuka; M Kronenberg
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

View more
  42 in total

1.  Slam haplotypes modulate the response to lipopolysaccharide in vivo through control of NKT cell number and function.

Authors:  Idil Aktan; Alan Chant; Zachary D Borg; David E Damby; Paige C Leenstra; Graham W J Lilley; Graham W G Lilley; Joseph Petty; Benjamin T Suratt; Cory Teuscher; Edward K Wakeland; Matthew E Poynter; Jonathan E Boyson
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

Review 2.  Antigen-presenting cell function in the tolerogenic liver environment.

Authors:  Angus W Thomson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-11       Impact factor: 53.106

3.  NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge.

Authors:  Adam P Uldrich; Nadine Y Crowe; Konstantinos Kyparissoudis; Daniel G Pellicci; Yifan Zhan; Andrew M Lew; Philippe Bouillet; Andreas Strasser; Mark J Smyth; Dale I Godfrey
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

Review 4.  Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant.

Authors:  Neal N Padte; Xiangming Li; Moriya Tsuji; Sandhya Vasan
Journal:  Clin Immunol       Date:  2010-12-24       Impact factor: 3.969

Review 5.  The role of invariant natural killer T cells in lupus and atherogenesis.

Authors:  Amy S Major; Ram R Singh; Sebastian Joyce; Luc Van Kaer
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 6.  Harnessing invariant NKT cells in vaccination strategies.

Authors:  Vincenzo Cerundolo; Jonathan D Silk; S Hajar Masri; Mariolina Salio
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

Review 7.  Invariant natural killer T cells in adipose tissue: novel regulators of immune-mediated metabolic disease.

Authors:  M Rakhshandehroo; E Kalkhoven; M Boes
Journal:  Cell Mol Life Sci       Date:  2013-07-09       Impact factor: 9.261

Review 8.  The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.

Authors:  S L Cardell
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

9.  During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment.

Authors:  Malcolm S Duthie; Stuart J Kahn
Journal:  Immunology       Date:  2006-07-26       Impact factor: 7.397

10.  Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation.

Authors:  Norihito Kawasaki; Jose Luis Vela; Corwin M Nycholat; Christoph Rademacher; Archana Khurana; Nico van Rooijen; Paul R Crocker; Mitchell Kronenberg; James C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.